CEACAM5 siRNA |
|||
20-abx911389 | Abbexa |
|
|
CEACAM5 Peptide |
|||
7453P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) CEACAM5 Peptide |
CEACAM5 Antibody |
|||
32099 | SAB | 100ul | EUR 439 |
CEACAM5 Antibody |
|||
32099-100ul | SAB | 100ul | EUR 302.4 |
CEACAM5 Antibody |
|||
E19-6152 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
CEACAM5 Antibody |
|||
E10-31505 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
CEACAM5 Antibody |
|||
E90970 | EnoGene | 100ul | EUR 255 |
Description: Available in various conjugation types. |
CEACAM5 Antibody |
|||
DF6152 | Affbiotech | 200ul | EUR 420 |
CEACAM5 Antibody |
|||
DF6152-100ul | Affinity Biosciences | 100ul | EUR 280 |
CEACAM5 Antibody |
|||
DF6152-200ul | Affinity Biosciences | 200ul | EUR 350 |
CEACAM5 Antibody |
|||
E310841 | EnoGene | 200ul | EUR 275 |
Description: Available in various conjugation types. |
CEACAM5 Antibody |
|||
1-CSB-PA005033 | Cusabio |
|
|
Description: A polyclonal antibody against CEACAM5. Recognizes CEACAM5 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
CEACAM5 Antibody |
|||
CSB-PA005165KA01HU- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against CEACAM5. Recognizes CEACAM5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200 |
CEACAM5 Antibody |
|||
CSB-PA005165KA01HU-100ul | Cusabio | 100ul | EUR 466.8 |
Description: A polyclonal antibody against CEACAM5. Recognizes CEACAM5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200 |
CEACAM5 Antibody |
|||
1-CSB-PA005165LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against CEACAM5. Recognizes CEACAM5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:200-1:500, IF:1:50-1:200 |
CEACAM5 Antibody |
|||
7453-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: CEACAM5 is a member of the carcinoembryonic antigen (CEA) family, which belongs to the immunoglobulin superfamily (1,2). CEACAM proteins are involved in cell-cell recognition and modulate cellular processes that range from the shaping of tissue architecture and neovascularization to the regulation of insulin homeostasis and T-cell proliferation (2). CEACAM5 has been shown to be overexpressed in a majority of carcinomas and has been suggested to be a intercellular adhesion molecule involved in cancer invasion and metastasis (3). |
CEACAM5 Antibody |
|||
7453-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: CEACAM5 is a member of the carcinoembryonic antigen (CEA) family, which belongs to the immunoglobulin superfamily (1,2). CEACAM proteins are involved in cell-cell recognition and modulate cellular processes that range from the shaping of tissue architecture and neovascularization to the regulation of insulin homeostasis and T-cell proliferation (2). CEACAM5 has been shown to be overexpressed in a majority of carcinomas and has been suggested to be a intercellular adhesion molecule involved in cancer invasion and metastasis (3). |
CEACAM5 Antibody |
|||
ABD6152 | Lifescience Market | 100 ug | EUR 525.6 |
CEACAM5 Antibody |
|||
1-CSB-PA229032 | Cusabio |
|
|
Description: A polyclonal antibody against CEACAM5. Recognizes CEACAM5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
CEACAM5 Antibody |
|||
1-CSB-PA097333 | Cusabio |
|
|
Description: A polyclonal antibody against CEACAM5. Recognizes CEACAM5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100 |
CEACAM5 Antibody |
|||
1-CSB-PA109108 | Cusabio |
|
|
Description: A polyclonal antibody against CEACAM5. Recognizes CEACAM5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100 |
CEACAM5 Antibody |
|||
1-CSB-PA160116 | Cusabio |
|
|
Description: A polyclonal antibody against CEACAM5. Recognizes CEACAM5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
CEACAM5 Antibody |
|||
R30120 | NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: CEA(Carcinoembryonic antigen) is a glycoprotein involved in cell adhesion. It is normally produced during fetal development, but the production of CEA stops before birth. Therefore, it is not usually present in the blood of healthy adults, although levels are raised in heavy smokers. CEA is a glycosyl phosphatidyl inositol(GPI)-cell surface anchored glycoprotein whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. CEA and related genes make up the CEA family belonging to the immunoglobulin superfamily. In humans, the carcinoembryonic antigen family consists of 29 genes, 18 of which are normally expressed. |
CEACAM5 Antibody |
|||
K11082M05G07C-100ug | Absea Biotechnology | 100 ug | EUR 320 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M05G07C-1mg | Absea Biotechnology | 1 mg | EUR 1600 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M05G07C-50ug | Absea Biotechnology | 50 ug | EUR 224 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M07G04C-100ug | Absea Biotechnology | 100 ug | EUR 320 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M07G04C-1mg | Absea Biotechnology | 1 mg | EUR 1600 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M07G04C-50ug | Absea Biotechnology | 50 ug | EUR 224 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M09H04C-100ug | Absea Biotechnology | 100 ug | EUR 320 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M09H04C-1mg | Absea Biotechnology | 1 mg | EUR 1600 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M09H04C-50ug | Absea Biotechnology | 50 ug | EUR 224 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M10G02C-100ug | Absea Biotechnology | 100 ug | EUR 320 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M10G02C-1mg | Absea Biotechnology | 1 mg | EUR 1600 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M10G02C-50ug | Absea Biotechnology | 50 ug | EUR 224 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M15A12C-100ug | Absea Biotechnology | 100 ug | EUR 400 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M15A12C-1mg | Absea Biotechnology | 1 mg | EUR 2000 |
Description: Monoclonal Antibody |
CEACAM5 Antibody |
|||
K11082M15A12C-50ug | Absea Biotechnology | 50 ug | EUR 280 |
Description: Monoclonal Antibody |
CEACAM5 Lentivirus |
|||
78719 | BPS Bioscience | 500 µl x 2 | EUR 795 |
Description: The CEACAM5 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human CEACAM5 (NM_004363.6) driven by an EF1A promoter and a puromycin selection marker (Figure 1)._x000D_ _x000D_Figure 1: Schematic of the lenti-vector used to generate the CEACAM5 Lentivirus |
CEACAM5 Mouse mAb |
|||
A18131 | Abclonal | 20 μL | EUR 83.2 |
Description: A synthetic peptide corresponding to a sequence within amino acids 1-100 of human Bcl-2 (P10415). |
CEACAM5 Mouse mAb |
|||
A18131-100ul | Abclonal | 100 ul | EUR 460.8 |
CEACAM5 Mouse mAb |
|||
A18131-200ul | Abclonal | 200 ul | EUR 664.8 |
CEACAM5 Mouse mAb |
|||
A18131-20ul | Abclonal | 20 ul | EUR 219.6 |
CEACAM5 Mouse mAb |
|||
A18131-50ul | Abclonal | 50 ul | EUR 318 |
CEACAM5 Mouse mAb |
|||
E2222170 | EnoGene | 100ul | EUR 255 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
CEACAM5 Rabbit pAb |
|||
E2511091 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
CEACAM5 Rabbit pAb |
|||
E2500970 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
CEACAM5 Rabbit pAb |
|||
A0970-100ul | Abclonal | 100 ul | EUR 369.6 |
CEACAM5 Rabbit pAb |
|||
A0970-200ul | Abclonal | 200 ul | EUR 550.8 |
CEACAM5 Rabbit pAb |
|||
A0970-20ul | Abclonal | 20 ul | EUR 219.6 |
CEACAM5 Rabbit pAb |
|||
A0970-50ul | Abclonal | 50 ul | EUR 267.6 |
CEACAM5 Rabbit pAb |
|||
A12421-100ul | Abclonal | 100 ul | EUR 369.6 |
CEACAM5 Rabbit pAb |
|||
A12421-200ul | Abclonal | 200 ul | EUR 550.8 |
CEACAM5 Rabbit pAb |
|||
A12421-20ul | Abclonal | 20 ul | EUR 219.6 |
CEACAM5 Rabbit pAb |
|||
A12421-50ul | Abclonal | 50 ul | EUR 267.6 |
CEACAM5 Rabbit mAb |
|||
A22266 | Abclonal | 50μL | EUR 83.2 |
Description: A synthetic peptide corresponding to a sequence within amino acids 65-164 of human CD3H (P20963). |
CEACAM5 Rabbit mAb |
|||
E2R90054 | EnoGene | 100ul | EUR 585 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
CEACAM5 cloning plasmid |
|||
CSB-CL005165HU-10ug | Cusabio | 10ug | EUR 840 |
Description: A cloning plasmid for the CEACAM5 gene. |
CEACAM5 Blocking Peptide |
|||
DF6152-BP | Affbiotech | 1mg | EUR 234 |
CEACAM5 Monoclonal Antibody |
|||
30322-100ul | SAB | 100ul | EUR 302.4 |
CEACAM5 Monoclonal Antibody |
|||
30322-50ul | SAB | 50ul | EUR 224.4 |
CEACAM5 Monoclonal Antibody |
|||
E918131 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
CEACAM5 Polyclonal Antibody |
|||
E912421 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
Polyclonal CEACAM5 Antibody |
|||
APR06834G | Leading Biology | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CEACAM5 . This antibody is tested and proven to work in the following applications: |
CEACAM5 Conjugated Antibody |
|||
C32099 | SAB | 100ul | EUR 476.4 |
CEACAM5 Recombinant Protein |
|||
92-685 | ProSci | 0.05 mg | EUR 588.3 |
Description: Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) belong to a group of mammalian immunoglobulin related glycoproteins. They play critical roles in cell–cell recognition. CEACAM5, also called CEA and CD66e, is characterized by having seven extracellular Ig domains and a glycosylphosphatidylinositol (GPI) anchor. CEACAM5 is expressed primarily by epithelial cells, and functions as a calcium-independent adhesion molecule through homophilic and heterophilic interactions with CEACAM1. Studies have shown that CEACAM5 is overexpressed in a majority of carcinomas, and its overexpression can protect tumor cells from apoptosis. It is commonly used as a cancer marker. |
CEACAM5 Recombinant Protein |
|||
92-705 | ProSci | 0.05 mg | EUR 588.3 |
Description: Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) belong to a group of mammalian immunoglobulin related glycoproteins. They play critical roles in cell–cell recognition. CEACAM5, also called CEA and CD66e, is characterized by having seven extracellular Ig domains and a glycosylphosphatidylinositol (GPI) anchor. CEACAM5 is expressed primarily by epithelial cells, and functions as a calcium-independent adhesion molecule through homophilic and heterophilic interactions with CEACAM1. Studies have shown that CEACAM5 is overexpressed in a majority of carcinomas, and its overexpression can protect tumor cells from apoptosis. It is commonly used as a cancer marker. |
CEACAM5 Polyclonal Antibody |
|||
E-AB-60116-120uL | Elabscience Biotech | 120uL | EUR 320 |
Description: Unconjugated |
CEACAM5 Polyclonal Antibody |
|||
E-AB-60116-200uL | Elabscience Biotech | 200uL | EUR 530 |
Description: Unconjugated |
CEACAM5 Polyclonal Antibody |
|||
E-AB-60116-60uL | Elabscience Biotech | 60uL | EUR 200 |
Description: Unconjugated |
CEACAM5 Polyclonal Antibody |
|||
E-AB-60116-each | Elabscience Biotech | each | Ask for price |
Description: Unconjugated |
CEACAM5, Avi-His-Tag |
|||
100509 | BPS Bioscience | 100 µg | EUR 330 |
Description: Human CEACAM5, also known as Carcinoembryonic antigen-related cell adhesion molecule 5, CEA, and CD66e, GenBank Accession No. NM_004363.6, a.a. 35-685 with a C-terminal Avi-His-TagTM, expressed in a HEK293 cell expression system. MW=75 kDa. |
Human CEACAM5 ELISA Kit |
|||
ELA-E0150h | Lifescience Market | 96 Tests | EUR 988.8 |
Human CEACAM5 shRNA Plasmid |
|||
20-abx950757 | Abbexa |
|
|
Mouse CEACAM5 shRNA Plasmid |
|||
20-abx977936 | Abbexa |
|
|
CEACAM5 (untagged)-Human carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) |
|||
SC126003 | Origene Technologies GmbH | 10 µg | Ask for price |
CEACAM5 Antibody, HRP conjugated |
|||
1-CSB-PA005165LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against CEACAM5. Recognizes CEACAM5 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
CEACAM5 Antibody, FITC conjugated |
|||
1-CSB-PA005165LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against CEACAM5. Recognizes CEACAM5 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
h CEACAM5 Expression Lentivirus |
|||
LVP1153 | GenTarget | 1x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CEACAM5, containing a RFP-Blasticidin dual selection marker. |
OASA02375-25UG - CEACAM5 Antibody |
|||
OASA02375-25UG | Aviva Systems Biology | 25ug | EUR 129 |
OASA02377-25UG - CEACAM5 Antibody |
|||
OASA02377-25UG | Aviva Systems Biology | 25ug | EUR 129 |
OALA06173-25UG - CEACAM5 Antibody |
|||
OALA06173-25UG | Aviva Systems Biology | 25ug | EUR 539 |
OAAF08274-50UL - CEACAM5 Antibody |
|||
OAAF08274-50UL | Aviva Systems Biology | 50ul | EUR 219 |
OAAN00144-50UL - CEACAM5 Antibody |
|||
OAAN00144-50UL | Aviva Systems Biology | 50ul | EUR 149 |
CEACAM5 Antibody, Biotin conjugated |
|||
1-CSB-PA005165LD01HU | Cusabio |
|
|
Description: A polyclonal antibody against CEACAM5. Recognizes CEACAM5 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
CEACAM5 Rabbit Polyclonal Antibody |
|||
53344 | SAB | 100ul | EUR 439 |
OASG00983-100UL - CEACAM5 Antibody |
|||
OASG00983-100UL | Aviva Systems Biology | 100ul | EUR 269 |
OAEC04731-100UL - CEACAM5 Antibody |
|||
OAEC04731-100UL | Aviva Systems Biology | 100ug/100ul | EUR 249 |
OAEE00305-100UG - CEACAM5 Antibody |
|||
OAEE00305-100UG | Aviva Systems Biology | 0.1mg | EUR 199 |
OASA02374-200UG - CEACAM5 Antibody |
|||
OASA02374-200UG | Aviva Systems Biology | 0.2mg | EUR 459 |